Graphite Bio Investor Relations Material
Latest events
M&A Announcement
Graphite Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Graphite Bio Inc
Access all reports
Graphite Bio Inc is a biotechnology company engaged in the development of gene editing therapies for the treatment of serious genetic diseases. Its research focuses on employing precise DNA repair mechanisms to create targeted and durable treatments. The company primarily serves the healthcare and pharmaceutical sectors. Graphite Bio Inc is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
GRPH
Country
🇺🇸 United States